Effect of casting solvent on crystallinity of ondansetron in transdermal films

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 106-110

  Pattnaik, Satyanarayan ^a   Swain, Kalpana ^a   Mallick, Subrata ^b   Lin, Zhiqun ^c  

^a Department of Pharmaceutics   (India)

^b SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^c Iowa State University of Science and Technology   (United States)

Author keywords

Casting solvent; Ondansetron hydrochloride; Polymeric system; Transdermal delivery

Indexed keywords

CASTING SOLVENT; CHLOROFORM; CRYSTALLIN; DICHLOROMETHANE; ETHYL CELLULOSE; METHANOL; ONDANSETRON; POLYMER; POVIDONE; SOLVENT; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; MELTING POINT; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSDERMAL PATCH; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; MICROSCOPY, ELECTRON, SCANNING; ONDANSETRON; SOLVENTS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL; TRANSDERMAL PATCH; X-RAY DIFFRACTION;

EID: 79951580902     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.009     Document Type: Article

References (16)

1. Biali, F.I., Scasso, A.F., Stefano, F.J.E., 2002. Inhibition of crystallization in transdermal devices. US Patent 6,465,005.
2. F. Cilurzo, P. Minghetti, A. Casiraghi, L. Tosi, S. Pagani, and L. Montanari Polymethacrylates as crystallization inhibitors in monolayer transdermal patches containing ibuprofen Eur. J. Pharm. Biopharm. 60 2005 61 66 (Pubitemid 40545861)
3. E. Cho, H. Gwak, and I. Chun Formulation and evaluation of ondansetron nasal delivery systems Int. J. Pharm. 349 2008 101 107 (Pubitemid 350299693)
4. J.X. Guo, and D.G. Gray Chiroptical behavior of (acetyl)(ethyl)cellulose liquid-crystalline solutions in chloroform Macromolecules 22 1989 2086 2090
5. A.H. Kibbe, R. Povidone, C.P. Rowe, and J.S. Sheskey C. Owen, Hand Book of Pharmaceutical Excipients, 2005 Pharmaceutical press UK pp. 1617-1627
6. J.H. Kim, and H.K. Choi Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix Int. J. Pharm. 236 2002 81 85
7. P.N. Kotiyan, and P.R. Vavia Eudragits: role as crystallization inhibitors in drug in adhesive transdermal systems of estradiol Eur. J. Pharm. Biopharm. 52 2001 173 180 (Pubitemid 32755896)
8. Lipp, R., Riedl, J., Tack, J., 1997. Transdermal therapeutic systems with crystallization inhibitors. US Patent 5,676,968.
9. S. Mallick, S. Pattnaik, K. Swain, P.K. De, A. Saha, G. Ghosal, and A. Mondal Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin Eur. J. Pharm. Biopharm. 68 2008 346 351
10. N.A. Megrab, A.C. Williams, and B.W. Barry Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation J. Control Release 36 1995 277 294
11. S. Pattnaik, K. Swain, and S. Mallick Influence of polymeric system and loading dose on drug release from alfuzosin hydrochloride transdermal films Lat. Am. J. Pharm. 28 2009 62 69
12. S. Pattnaik, K. Swain, P. Choudhury, P.K. Acharya, and S. Mallick Alfuzosin hydrochloride transdermal films: Evaluation of physicochemical, in vitro human cadaver skin permeation and thermodynamic parameters Int. Braz. J. Urol. 35 2009 716 729
13. M.A. Pellet, S. Castellano, J. Hadgraft, and A. Davis The permeation of solutions of piroxicam across silicon membranes and human skin in vitro J. Controlled Release 46 1997 205 217
14. M.A. Pellet, J. Hadgraft, and A.F. Davis The permeation of solutions of piroxicam across silicon membranes and human skin in vitro Int. J. Pharm. 111 1994 1 6
15. S.L. Raghavan, A. Trividic, A.F. Davis, and J. Hadgraft Crystallization of hydrocortisone acetate: influence of polymers Int. J. Pharm. 212 2001 213 221 (Pubitemid 32119447)
16. F.P. Schwarb, G. Imanidis, E.W. Smith, J.M. Haigh, and C. Surber Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin Pharm. Res. 16 1999 909 915 (Pubitemid 29284204)